A recent paper using mass spectrometry suggests an ordered occurrence of post-translational modifications (PTMs) on tau that coincides with tau aggregation processes and NFT formation, with a specific subset indicating a higher prevalence in AD [60]. The gene discussed is MAPT; the disease is Alzheimer disease.